FRX Said FDA Issues Non-Approvable letter Related to Namenda Label Expansion
Tweet Send to a Friend
Forest Laboratories, Inc. (NYSE: FRX) said the has issued a non-approvable ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
